BioCentury
ARTICLE | Clinical News

LeukoScan antibody fragment targeting white blood cells data

September 23, 1996 7:00 AM UTC

IMMU reported that initial analysis of 74 patients in a Phase III trial has found a true-positive rate of 100 percent and a true-negative rate of 94 percent. This means that most patients presenting with symptoms of atypical appendicitis but with a negative result with LeukoScan do not require immediate surgery. When the test was positive, all patients had an infectious lesion at surgery that required immediate removal. ...